¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"conversion period"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® incubation period, latent stage ÇÑ±Û Àẹ±â, ¹è¾ç±â°£
¼³¸í   
  1. º´¿øÃ¼°¡ Ã¼³»¿¡ Ä§ÀÔ(°¨¿°)ÇÑ ÈÄ ±×·Î ÀÎÇÑ °¨¿°ÁõÀÌ ¹ßº´ÇÒ ¶§±îÁöÀÇ ±â°£. º´¿øÃ¼ÀÇ Á¾·ù¿¡ µû¶ó ±× ³»¿ëÀÌ ´Ù¸£´Ù. ¿¹ÄÁ´ë ¸»¶ó¸®¾Æ´Â Ä§ÀÔÇÑ º´¿øÃ¼°¡ ÀÎü ³»¿¡¼­ ÀÏÁ¤ÇÑ ´Ü°è±îÁö ¹ßÀ°ÇÑ ÈÄ ¹ßº´Çϰí, ÀåÆ¼Çª½º´Â Ä§ÀÔÇÑ º´¿ø±ÕÀÌ ÀÏÁ¤ÇÑ ¼ö±îÁö ¹ø½ÄÀ» Çؾߠ¹ßº´Çϸç, ÆÄ»ódzÀº Ä§ÀÔÇÑ º´¿ø±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò°¡ ³ú½Å°æ¿¡ ´ÞÇÑ ÈÄ¿¡ ¹ßº´ÇÑ´Ù. °°Àº º´À̶󵵠ħÀÔÇÑ º´¿øÃ¼ÀÇ ¾çÀ̳ª µ¶·Â, °¨¿°µÈ »ç¶÷ÀÇ °¨¼ö¼º µî¿¡ µû¶ó¼­µµ ´Þ¶óÁø´Ù. º¸Åë Àẹ±â¿¡´Â º´Àû Â¡Èİ¡ ³ªÅ¸³ªÁö ¾ÊÁö¸¸ ¹Î°¨ÇÑ »ç¶÷ÀÇ °æ¿ì´Â µÎÅë-½Ä¿åºÎÁø-Çö±âÁõ-ºÒÄè°¨°ú °°Àº Àü±¸Áõ»óÀ» ³ªÅ¸³»´Â ¼öµµ ÀÖ´Ù. 2. º¸¿Â±â°£, ¹è¾ç±â°£, ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 
¿µ¹® conversion ÇÑ±Û Àüȯ
¼³¸í   
  1. ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °Í. 2. ¾î¶² º´À̳ª ¹ÝÀÀÀÌ ÇÑ »óÅ¿¡¼­ ´Ù¸¥ »óÅ·Πº¯Çϴ °Í.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • conversion disorder
    ÀüȯÀå¾Ö
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • digital scan conversion
    µðÁöÅнºÄµÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • hysterical conversion
    È÷½ºÅ׸®Àüȯ
  • internal conversion
    ³»ºÎº¯È¯
  • positive conversion
    ¾ç¼ºÀüȯ
  • peripheral conversion
    ¸»ÃÊÀüȯ
  • roentgen-to-rad conversion factor
    ·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ
  • peripheral conversion
    ¸»ÃÊÀüȯ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • period
    ÁÖ±â
  • ejection period
    ¹ÚÃâ±â
  • incubation period
    Àẹ±â
  • induction period
    À¯µµ±â
  • involutional period
    °»³â±â
  • lag period
    Áõ½ÄÁغñ±â, Áö¿¬±â
  • latent period
    ÀáÀç±â , Àẹ±â
  • neonatal period
    ½Å»ý¾Æ±â
  • paroxysmal period
    ¹ßÀÛ±â
  • postmenopausal period
    Æó°æÈıâ
  • premenstrual period
    ¿ù°æÀü±â
  • prenatal period
    ºÐ¸¸Àü±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • congenital conversion nipple
    ¼±ÃµÀüȯÀ¯µÎ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • gene conversion
    À¯ÀüÀÚº¯È¯
  • hysterical conversion
    È÷½ºÅ׸®Àüȯ
  • internal conversion
    ³»ºÎº¯È¯
  • lysogenic conversion
    ¿ë¿øÀüȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SPCA= serum prothrombin conversion a
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüÈ­ÃËÁø¼Ò.
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • gene conversion
    À¯ÀüÀÚº¯È¯.
  • gene conversion
    À¯ÀüÀÚº¯È¯(ܨüµ).
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ.
  • hysterical conversion
    ÀüȯÈ÷½ºÅ׸®,È÷½ºÅ׸®Àüȯ(¡­ï®üµ)
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • positive conversion
    ¾çÀü(È­)
  • Oedipal period
    ¿¡µðǪ½º½Ã±â(¡­ãÁÑ¢).
  • absolute refractory period
    Àý´ëºÒÀÀ±â(¡­ÝÕëëÑ¢)
  • alveolar period
    ²Ê¸®½Ã±â
  • generalization period
    ¸¸¿¬±â(ËÎËçË»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ(ï®üµ).
  • conversion disorder
    ÀüȯÀå¾Ö(ï®üµî¡äô)., Àüȯº´
  • conversion factor
    º¯È¯ ÀÎÀÚ
  • conversion heat
    Àüȯ¿­(ï®üµæð).
  • conversion neurosis
    Àüȯ½Å°æÁõ(ï®üµ ãêÌèñø)., Àüȯ½Å°æº´
  • conversion rate
    ÀüȯÀ²(ï®üµëÒ).
  • conversion rate
    ÀüȯÀ²(ËøÌ·Ëô).
  • conversion reaction
    Àüȯ¹ÝÀÀ(ï®üµÚãëë).
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • conversion, lysogenic
    ¿ë¿ø¼ºÀüȯ
  • conversion, phage
    ÆÄÁöÀüȯ
  • digital scan conversion
    ¼ýÀÚ ½ºÄµ º¯È¯ (ܨüµ)
  • digital scan conversion
    µðÁöÅÐ ½ºÄµ º¯È¯
  • direct conversion x-ray detector
    Á÷Á¢ º¯È¯ X¼± °ËÃâ±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Pseudoglandular period
    °ÅÁþ»ù½Ã±â
    [¿¾ ¿ë¾î] À§¼±±â
  • Alveolar period
    ²Ê¸®½Ã±â
    [¿¾ ¿ë¾î] ÆóÆ÷±â
  • Prenatal period
    ºÐ¸¸Àü±â
    [¿¾ ¿ë¾î] ºÐ¸¸Àü±â
  • Postnatal period
    ºÐ¸¸Èıâ
    [¿¾ ¿ë¾î] ºÐ¸¸Èıâ
  • Canalicular period
    ¼¼°ü½Ã±â
    [¿¾ ¿ë¾î] ¼¼°ü±â
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Initial period of neural groove
    ½Å°æ°í¶ûÃʱâ
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÀü±â
  • Period of neural tube
    ½Å°æ°ü±â
    [¿¾ ¿ë¾î] ½Å°æ°ü±â
  • Neonatal period
    ½Å»ý¾Æ±â
    [¿¾ ¿ë¾î] ½Å»ý¾Æ±â
  • Intermitotic period [Interphase]
    À¯»çºÐ¿­»çÀ̱â
    [¿¾ ¿ë¾î] °£±â
  • Mesoderm of the period of branchiogenesis
    ÀεαÁÀ̹߻ý±âÁ߹迱
    [¿¾ ¿ë¾î] ÀεαÃ[»õ±Ã]¹ß»ý±âÁ߹迱
  • Final period of branchial arch
    ÀεαÁÀÌÁ¾±â
    [¿¾ ¿ë¾î] »õ±ÃÁ¾±â
  • Initial period of pharyngeal arch
    ÀεαÁÀÌÃʱâ
    [¿¾ ¿ë¾î] ÀεαÃÀü±â(»õ±ÃÀü±â)
  • Gestational period
    Àӽűâ
    [¿¾ ¿ë¾î] Àӽűâ
  • Period of labial fissure
    ÀÔ¼úÆ´»õ±â
    [¿¾ ¿ë¾î] ±¸¼ø¿­±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • extrinsic incubation period
    ¸ð±â³»Àẹ±â
  • incubation period
    Àẹ±â
  • latent period
    Àẹ±â
  • prepatent period
    ÃæÃ¼Àẹ±â
  • residual period
    ÀÜ·ù±â°£
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion period
    Àüȯ±â°£(ï®üµÑ¢Êà)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • incubation period
    Àẹ±â(íÖÜÑÑ¢)
  • induction period
    À¯µµ±â°£(ë¯ÓôÑ¢Êà)
  • lag period
    Áöü½Ã°£(òÀôòãÁÊà)
  • latent period
    Àẹ±â(íÖÜÑÑ¢)
  • long period intersperion
    Àå±â »êÀç(íþѢߤî¤)
  • short period intespersion
    ´Ü±â°£ »êÀç(Ó­Ñ¢Êàߤî¤)
  • unit evolutionary period
    ´ÜÀ§(Ó¤êÈ) ÁøÈ­±â°£ (òäûùÑ¢Êà)
  • antigenic conversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ)
  • conversion
    Àüȯ(ï®üµ)
  • conversion coefficient
    Àüȯ°è¼ö(ï®üµÌõâ¦)
  • conversion electron
    ÀüȯÀüÀÚ(ï®üµï³í­)
  • conversion factor
    ÀüȯÀÎÀÚ(ï®üµì×í­)
  • conversion stage
    Àüȯ½Ã±â(ï®üµãÁÑ¢)
  • gene conversion
    À¯ÀüÀÚ Àüȯ(ë¶îîí­ï®üµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ, º¯È¯, º¯Á¶, ÀüÈ­
  • conversion factor
    º¯È¯ÀÎÀÚ
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • direct conversion x-ray detector
    Á÷Á¢º¯È¯X¼±°ËÃâ±â
  • incubation period
    Àẹ±â, º¸¿Â±â°£, ¹è¾ç±â°£
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ±â°£
  • period
    ÁÖ±â, ±â, ±â°£, ½Ã´ë
  • pulse repetition period
    ÆÞ½º¹Ýº¹ÁÖ±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HFRS Hemorrhagic Fever with Renal Syndrome [HP 849-50]
  = Korean Hemorrhagic Fever
&nbs...
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
PPCA plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator
AERP antegrade effective refractory period; atrial effective refractory period
ARP absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
(14)C Conversion of
1-14C Conversion of
4-14C Conversion of
(14)C conversion of L
DC Degree of conversion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
  • conversion disorder
    Àüȯ Àå¾Ö
    1. ±âÁúÀû ÁúȯÀÌ ¾øÀÌ ¹«ÀǽÄÀûÀÎ ¿ä±¸³ª °¥µîÀ¸·Î ÀÎÇÑ °¨°¢À̳ª ¿îµ¿ ±â´ÉÀÇ Àå¾Ö°¡ Ư¡ÀÎ Á¤½Å Áúȯ. 2. ½Å°æÇÐÀû ¶Ç´Â ³»°úÀû ÁúȯÀÌ ¾øÀÌ ¸¶ºñ, ½Ã·Â »ó½Ç, ÇÔ±¸Áõ
  • conversion factor
    º¯È¯ °è¼ö
  • conversion rate
    ÀüȯÀ²
  • hysteria conversion
    Àüȯ È÷½ºÅ׸®, È÷½ºÅ׸® Àüȯ
    ºÒ¾ÈÀ» ½ÅüÀû ¡ÈÄ ¶Ç´Â Áõ»óÀ¸·Î Àüȯ½ÃÄÑ, ºÒ¾ÈÀ» ¹Ù²Ù¾î ³õ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â È÷½ºÅ׸®.
  • salt water conversion kit
    ¿°·ù º¯È¯ Ŷ
  • alveolar period
    ²Ê¸® ½Ã±â
  • childbearing period
    Àӽа¡´É ±â°£
  • competent period
    ¼ö¿ë±â
  • critical period
    ƯÁ¤Àû ½Ã±â
  • demi-period
    ¹Ý°¨±â
    ¹æ»ç¼º ¹°ÁúÀÇ ¹æ»ç·ÂÀÌ ÃÖÃÊÀÇ ¹æ»ç·ÂÀÇ ¹ÝÀ¸·Î ÁÙ¾îµå´Â ±â°£.
  • embryonic period
    ¹èÀÚ±â, ¹è¾Æ±â
  • eruption period of deciduous teeth
    À¯Ä¡ ¸ÍÃ⠽ñâ
  • formal operational period
    Çü½ÄÀû Á¶ÀÛ±â
  • incubation period
    Àẹ±â, Àẹ ±â°£, º¸¿Â ±â°£, ¹è¾ç ±â°£
    1. ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 2. Àẹ±â. ¿øÀÎ ±ÕÀÌ Ã¼³»¿¡ ħÀÔÇÑ ¼ø°£ºÎÅÍ ½ÃÀÛÇÏ¿© ÁúȯÀÇ ÃÖÃÊÀÇ Áõ»óÀÌ ³ªÅ¸³¯ ¶§±îÁöÀÇ ±â°£.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
analog-digital conversion The process of converting analog data such as continually measured voltage to discrete, digital form.
(12 Dec 1998)
bed conversion The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.
(12 Dec 1998)
biochemical conversion process The use of living organisms or their products to convert organic material to fuels.
(05 Dec 1998)
gene conversion <molecular biology> A phenomenon in which alleles are segregated in a 3:1 not 2:2 ratio in meiosis. May be a result of DNA polymerase switching templates and copying from the other homologous sequence or a result of mismatch repair (nucleotides being removed from one strand and replaced by repair synthesis using the other strand as template).
(18 Nov 1997)
plasmin prothrombins conversion factor <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
conversion An unconscious defense mechanism by which the anxiety that stems from intrapsychic conflict is converted and expressed in a symbolic somatic.
Origin: L. Con = with, versio = turning
(18 Nov 1997)
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
conversion electron An internal conversion electron.
(05 Mar 2000)
conversion hysteria Hysteria characterised by the substitution, through psychic transformation, of physical signs or symptoms for anxiety; generally restricted to such major symptoms as blindness, deafness, and paralysis, or lesser ones such as blurred vision and numbness.
Synonym: conversion hysteria neurosis, conversion neurosis, conversion reaction.
(05 Mar 2000)
conversion hysteria neurosis Hysteria characterised by the substitution, through psychic transformation, of physical signs or symptoms for anxiety; generally restricted to such major symptoms as blindness, deafness, and paralysis, or lesser ones such as blurred vision and numbness.
Synonym: conversion hysteria neurosis, conversion neurosis, conversion reaction.
(05 Mar 2000)
conversion neurosis Hysteria characterised by the substitution, through psychic transformation, of physical signs or symptoms for anxiety; generally restricted to such major symptoms as blindness, deafness, and paralysis, or lesser ones such as blurred vision and numbness.
Synonym: conversion hysteria neurosis, conversion neurosis, conversion reaction.
(05 Mar 2000)
conversion reaction A conversion of emotional stress or mental disturbance into a physical symptom.
Examples include paralysis, blindness, inability to speak or another sudden debilitating problem for no reason evident through testing.
(27 Sep 1997)
proserum prothrombin conversion accelerator A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs.
(12 Dec 1998)
serum prothrombin conversion accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
stand conversion The conversion of a noncommercial stand of timber to a commercial stand.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ; ÅÂȯ(ÅÂȯ)
  • conversion
    Àüȯ;ÀüÈ­(changing);(Áý.Â÷µîÀÇ)°³Àå;°³Á¶;º¯¼³;ÀüÇâ;°³Á¾;±ÍÀÇ (ƯÈ÷ ±âµ¶±³¿¡ÀÇ);(ÁÖ»ç¿Í ºó»ç¿ÍÀÇ)ȯÀ§(¹ý);(ºÎäÀÇ) Â÷ȯ;¹Ù²ãÁü;(ÁöÆóÀÇ)ÅÂȯ;(¿Ü±¹ÅëÈ­ÀÇ)ȯ»ê;ÀÌÀÚ¸¦ ¿ø±Ý¿¡ °¡»êÇϱâ;(Àç»êÀÇ)Àüȯ;(µ¿»êÀÇ)Ⱦ·É;Àüȯ(ÇÙ¿¬·á¹°ÁúÀÌ ´Ù¸¥ ÇÙ¿¬·á¹°Áú·Î º¯È­Çϱâ);~al;
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • conversion factor
    (¹®ÀÇ.ÀÚ·áû±¸¿¡¼­ ½ÇÁ¦ »óǰ±¸¸ÅÀÎÀ¸·ÎÀÇ)ÀüȯÀ²
  • conversion heater
    Àü¿­±â(electric heater)
  • conversion ratio
    Àüȯ ºñÀ²(Çٺп­½Ã ÇϳªÀÇ ¿øÀÚ¿¡¼­ »ý±â´Â ¿øÀÚÀÇ ¼ö
  • conversion table
    (µµ·®ÇüµîÀÇ)ȯ»êÇ¥
  • period
    ±â°£,½Ã´ë,Á¾ÁöºÎ
  • cooling-off period
    ³Ã°¢ ±â°£
  • glacial epoch(period)
    ºùÇϱâ(½Ã´ë)
  • glacial period
    ºùÇÏ ½Ã´ë
  • grace period
    À¯¿¹±â°£
  • halflife period
    (¹æ»ç¼º ¿ø¼Ò µîÀÇ)¹Ý°¨±â
  • honeymoon period
    (¹Ì)(´ëÅë·É ÃëÀÓÈÄ ¾à 3°³¿ù°£ÀÇ È£ÀǸ¦ ¹Þ´Â)¹Ð¿ù ±â°£
  • monthly period
    ¿ù°æ(±â°£)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á